Ubushinwa imiti ivura kanseri y'ibihaha

Kugenda Ubushinwa imiti ivura kanseri y'ibihaha Biragoye. Aka gatabo karatanga incamake y’imiti isanzwe, harimo kuvura no gukingira indwara, bikunze gukoreshwa mu Bushinwa mu kuvura kanseri y’ibihaha, hamwe n’amakuru ajyanye n’igeragezwa ry’amavuriro ndetse no kubona uburyo bwo kuvura udushya. Kumva imiti ivura kanseri y'ibihaha mu Bushinwa Kanseri y'ibihaha ni ikibazo gikomeye ku buzima mu Bushinwa, kandi uburyo bwo kuvura burahora butera imbere. Gusobanukirwa ubwoko bwa kanseri y'ibihaha hamwe nuburyo bwo kuvura buhari ni ngombwa ku barwayi n'imiryango yabo. Ubwoko bwa Kanseri y'ibihaha Ubwoko bubiri bwa kanseri y'ibihaha ni:Kanseri y'ibihaha itari ntoya (NSCLC): Ubu ni bwo bwoko bukunze kugaragara, bingana na 80-85% by'abanduye kanseri y'ibihaha. Ubwoko butandukanye burimo adenocarcinoma, kanseri y'udukoko twa kanseri, na kanseri nini.Kanseri y'ibihaha ntoya (SCLC): Ubu bwoko ntibukunze kugaragara kandi bukunda gukura no gukwirakwira vuba kurusha NSCLC. Uburyo bwo Kuvura Bisanzwe Uburyo bwo kuvura kanseri y'ibihaha mu Bushinwa busanzwe bukubiyemo guhuza uburyo, harimo: SurgeryRadiation therapyChemotherapyTargeted therapyImmunotherapyChemotherapy Imiti ya Kanseri y'ibihaha mu Bushinwa Imiti ya chimiotherapie ikoreshwa mu kwica selile kanseri mu mubiri. Imiti isanzwe ya chimiotherapie ikoreshwa mu Bushinwa kuri kanseri y'ibihaha harimo:Ibiyobyabwenge bishingiye kuri platine: Cisplatine, CarboplatineAmatagisi: Paclitaxel, InyandikoGemcitabineVinorelbinePemetrexedIyi miti ikoreshwa kenshi hamwe, kandi gahunda yihariye izaterwa n'ubwoko bwa kanseri y'ibihaha, ndetse n'ubuzima bw'umurwayi muri rusange. Imiti igamije kuvura kanseri y'ibihaha mu Bushinwa Imiti igamije kuvura ikora yibasira molekile zihariye zigira uruhare mu mikurire ya kanseri no gukwirakwira. Iyi miti ikoreshwa kenshi muri NSCLC hamwe na mutation yihariye ya genetike.Ibikoresho bya EEGFR (epidermal growth factor reseptor) inhibitor ikoreshwa kubarwayi bafite NSCLC bafite ihinduka rya EGFR. Inzitizi rusange za EGFR ziboneka mubushinwa zirimo:GefitinibErlotinibAfatinibOsimertinibALK InhibitorALK (anaplastique lymphoma kinase) inhibitor zikoreshwa kubarwayi bafite NSCLC bafite ALK gene rerangements. Ibisanzwe ALK inhibitor ziboneka mubushinwa harimo:CrizotinibCeritinibAlectinibUbundi buvuzi bugenewe Ubundi buryo bwo kuvura bushobora gukoreshwa bitewe n’imiterere yihariye ihindagurika igaragara muri selile. Muri byo harimo:ROS1 inhibitor: Ku barwayi bafite genoside ya ROS1.Inzitizi za BRAF: Ku barwayi bafite ihinduka rya BRAF.MET inhibitor: Ku barwayi bafite MET exon 14 basimbuka mutation.Imiti yubuvuzi Imiti ya Kanseri yibihaha mu BushinwaImiti yubuvuzi ifasha sisitemu yumubiri yumubiri kumenya no gutera kanseri ya kanseri. Iyi miti ikoreshwa kenshi muri NSCLC yateye imbere. Ibisanzwe PD-1 / PD-L1 ibuza kuboneka mubushinwa harimo:PembrolizumabNivolumabAtezolizumabDurvalumabSintilimabTislelizumabIyi miti irashobora gukoreshwa wenyine cyangwa ifatanije na chimiotherapie.Igeragezwa rya kanseri ya kanseri y'ibihaha mu Bushinwa Ibizamini bya kliniki bitanga abarwayi kubona uburyo bushya kandi bushya bwo kuvura kanseri y'ibihaha. Ibitaro byinshi n’ibigo by’ubushakashatsi mu Bushinwa bikora ibizamini bya kanseri y'ibihaha. Abarwayi barashobora gushakisha ibizamini byamavuriro babinyujije kurubuga nka Amavuriro.gov na Kwiyandikisha Kugerageza Ibiyobyabwenge byabashinwa ( Ubushinwa imiti ivura kanseri y'ibihaha irashobora gutandukana bitewe nibintu nkubwishingizi hamwe nibitaro. Imiti myinshi igezweho ubu yashyizwe kurutonde rwigihugu rw’ibiyobyabwenge (NRDL), rushobora kugabanya cyane ibiciro by’abarwayi. Birasabwa kugisha inama abaganga ba oncologiste nabashinzwe ubuvuzi kugirango basobanukirwe nuburyo buboneka no kuyobora sisitemu yubuzima. Shandong Baofa Ikigo Cyubushakashatsi cya Kanseri (baofahospital.com) bihariwe guteza imbere kuvura kanseri nubushakashatsi, kureba ko abarwayi bafite uburyo bwo kuvura butanga ikizere kiboneka, harimo no guhanga udushya Ubushinwa imiti ivura kanseri y'ibihaha.Gusuzuma ibiciro byo kuvuraIbiciro byo kuvura kanseri y'ibihaha birashobora kuba impungenge zikomeye. Gusobanukirwa ubwishingizi, gahunda zifasha amafaranga, hamwe na NRDL irashobora gufasha abarwayi gucunga amafaranga yo kwivuza. Gutohoza uburyo hamwe nabakozi bashinzwe imibereho myiza hamwe nabajyanama mubyimari mubitaro nabyo ni byiza. Gutekereza kubuvuzi gakondo bwabashinwa (TCM) Ubuvuzi gakondo bwabashinwa (TCM) bukoreshwa nkubuvuzi bwuzuzanya hamwe nubuvuzi busanzwe bwa kanseri yibihaha mubushinwa. Bamwe mu barwayi basanga TCM ifasha mu gucunga ingaruka no kuzamura imibereho. Nyamara, ni ngombwa kuganira ku mikoreshereze ya TCM hamwe n’umuganga wawe wa oncologue kugirango umenye neza ko itabangamiye gahunda yawe isanzwe yo kuvura.Ingaruka zikomeye n’ubuyobozi Imiti ya kanseri y’ibihaha irashobora gutera ingaruka mbi, zitandukanye bitewe n’imiti yihariye. Ingaruka zisanzwe zirimo umunaniro, isesemi, kuruka, impiswi, no kurwara uruhu. Gucunga ingaruka ni igice cyingenzi mubikorwa byo kuvura. Itsinda ryanyu ryita ku buzima rirashobora gutanga ubuyobozi ku buryo bwo guhangana n’ingaruka no kuzamura imibereho yawe. Iterambere rya nyuma mu kuvura Kanseri y’ibihaha mu Bushinwa Urwego rwo kuvura kanseri y'ibihaha rugenda rwiyongera. Komeza umenyeshe ibyagezweho muri Ubushinwa imiti ivura kanseri y'ibihaha hamwe nuburyo bwo kugisha inama abashinzwe ubuzima no kugendana nibitabo byubuvuzi. Ubushakashatsi bwakozwe n’ibigo nka Shandong Baofa Ikigo cy’ubushakashatsi cya kanseri gihora kigira uruhare mu bumenyi bugenda bwiyongera mu kuvura kanseri. Inshamake y'imiti isanzwe ya kanseri y'ibihaha mu Bushinwa Iyi mbonerahamwe ivuga muri make imiti isanzwe ikoreshwa mu kuvura kanseri y'ibihaha mu Bushinwa. Ubwoko bw'imiti Ingero zisanzwe Gukoresha Chimiotherapie Cisplatin, Carboplatin, Paclitaxel, Gemcitabine Kwica kanseri ya kanseri umubiri wose EGFR Inhibitor Gefitinib, Erlotinib, Osimertinib NSCLC hamwe na mutation ya EGFR ALK Inhibitor Crizotinib, Ceritinib, Alectinib NSCLC hamwe na PDK Pembrolizumab, Nivolumab, Atezolizumab Yambere NSCLC; gufasha sisitemu yumubiri kurwanya kanseri Inshingano: Aya makuru agamije amakuru gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa kugira ngo zisuzume kandi zivure kanseri y'ibihaha. Baza muganga wawe mbere yo gufata ibyemezo byose bijyanye no kwivuza cyangwa kukwitaho. Buri gihe shakisha inama zinzobere mubuvuzi kubibazo byose bijyanye nubuzima bwawe bwihariye.